Study of AT-752 in Patients With Dengue Infection
Trial details
- Registry ID
- NCT05466240
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of AT-752 in Patients With Dengue InfectionNCT05466240 | AVIR | Phase 2 | Terminated | 2023-01-19Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |